Icares Medicus Inc
ICARES Medicus, Inc., together with its subsidiaries, engages in the research, development, manufacturing, and sale of ophthalmic medical devices in Taiwan, the United States, England, Japan, Spain, China, and internationally. The company is also involved in the manufacturing, sales, and service of intraocular lenses (IOLs) and its implantation systems for use in treating cataracts, myopia, hyper… Read more
Icares Medicus Inc (6612) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.042x
Based on the latest financial reports, Icares Medicus Inc (6612) has a cash flow conversion efficiency ratio of -0.042x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-78.58 Million) by net assets (NT$1.89 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Icares Medicus Inc - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how Icares Medicus Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Icares Medicus Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Icares Medicus Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
SOLTEC POWER HOLD. EO-25
F:5PZ
|
N/A |
|
SAMSE SA INH. EO 1
F:78S
|
N/A |
|
Journey Energy Inc
OTCQX:JRNGF
|
0.037x |
|
Malindo Feedmill Tbk
JK:MAIN
|
-0.003x |
|
EURO PRATIK SALES LIMITED
NSE:EUROPRATIK
|
N/A |
|
STX Corporation
KO:011810
|
-0.060x |
|
Sixxon Tech Co Ltd
TW:4569
|
0.045x |
|
UPDATER SERVICES LIMITED
NSE:UDS
|
N/A |
Annual Cash Flow Conversion Efficiency for Icares Medicus Inc (2017–2024)
The table below shows the annual cash flow conversion efficiency of Icares Medicus Inc from 2017 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | NT$1.76 Billion | NT$-10.82 Million | -0.006x | +60.26% |
| 2023-12-31 | NT$1.67 Billion | NT$-25.79 Million | -0.015x | -111.24% |
| 2022-12-31 | NT$937.76 Million | NT$128.92 Million | 0.137x | +192.61% |
| 2021-12-31 | NT$820.90 Million | NT$38.57 Million | 0.047x | -53.76% |
| 2020-12-31 | NT$702.42 Million | NT$71.37 Million | 0.102x | -25.26% |
| 2019-12-31 | NT$653.04 Million | NT$88.78 Million | 0.136x | +22.87% |
| 2018-12-31 | NT$571.42 Million | NT$63.22 Million | 0.111x | -18.11% |
| 2017-12-31 | NT$336.57 Million | NT$45.47 Million | 0.135x | -- |